受强制性开放获取政策约束的文章 - Max Mano了解详情
可在其他位置公开访问的文章：4 篇
Planning cancer control in Latin America and the Caribbean
PE Goss, BL Lee, T Badovinac-Crnjevic, K Strasser-Weippl, ...
The lancet oncology 14 (5), 391-436, 2013
强制性开放获取政策： US National Institutes of Health
Antiestrogen therapy is active in selected ovarian cancer cases: the use of letrozole in estrogen receptor–positive patients
JF Smyth, C Gourley, G Walker, MJ MacKean, A Stevenson, ...
Clinical Cancer Research 13 (12), 3617-3622, 2007
强制性开放获取政策： Cancer Research UK
Biomarker data from the phase III KATHERINE study of adjuvant T-DM1 versus trastuzumab for residual invasive disease after neoadjuvant therapy for HER2-positive breast cancer
C Denkert, C Lambertini, PA Fasching, KL Pogue-Geile, MS Mano, ...
Clinical Cancer Research 29 (8), 1569-1581, 2023
强制性开放获取政策： Health Research Board, Ireland
Breast cancer treatment delay in safetynet health systems, Houston versus Southeast Brazil
MN Shafaee, LR Silva, S Ramalho, MT Doria, R De Andrade Natal, ...
The oncologist 27 (5), 344-351, 2022
强制性开放获取政策： Susan G. Komen
出版信息和资助信息由计算机程序自动确定